stomach cancer

Shared gastric adenocarcinoma tumor features seem to span geography and ethnicity, despite shifts in the proportion of tumors from different molecular subtypes.

Under the deal, the parties will provide Perthera's Precision Cancer Analysis molecular profiling service to Hope for Stomach Cancer patients free of charge.

The Danish firm received FDA clearance to expand the intended use of its HercepTest and HER2 FISH pharmDx Kit to include patients with metastatic gastric or stomach cancer.

Industry observers have noted that the move from the outspoken Billy Tauzin, also known as the "Swamp Fox," to an insider business lobbyist-type like Castellani represents a shift in PhRMA's advocacy style. Where that leaves PhRMA's support for personalized medicine, a pet cause of Tauzin's, is hard to determine in the post-healthcare-reform climate in Washington.

New Releases

Premium

Dako's HercepTest and HER2 FISH pharmDx, Pathway Genomics' Genetic Health Report

Genentech will work with Dako in filing for clearance of the HercepTest and HER2 FISH pharmDx as companion diagnostics for Herceptin in treating patients with stomach cancer.

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.